MaxCyte, NIH NIAID Study Published in Science Translational Medicine Demonstrates CRISPR-Cas9 Repair of X … – Yahoo Finance
|
MaxCyte, NIH NIAID Study Published in Science Translational Medicine Demonstrates CRISPR-Cas9 Repair of X …
Yahoo Finance The study was published in Science Translational Medicinei and entitled "CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease." Using MaxCyte's patented Flow Electroporation™ Technology, … |
